© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
GraniteShares YieldBOOST Biotech ETF (BIOY) stock surged +0.04%, trading at $21.17 on NASDAQ, up from the previous close of $21.16. The stock opened at $21.19, fluctuating between $21.14 and $21.19 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 21.19 | 21.19 | 21.14 | 21.17 | 1.07K |
| Aug 20, 2026 | 21.41 | 21.41 | 21.38 | 21.38 | 859 |
| Aug 19, 2026 | 21.41 | 21.42 | 21.41 | 21.42 | 589 |
| Aug 18, 2026 | 21.19 | 21.24 | 21.19 | 21.24 | 839 |
| Aug 17, 2026 | 21.13 | 21.21 | 21.13 | 21.21 | 1.21K |
| Aug 14, 2026 | 20.82 | 21.07 | 20.78 | 21.07 | 4.4K |
| Aug 13, 2026 | 21.19 | 21.19 | 21.18 | 21.19 | 4.71K |
| Aug 12, 2026 | 21.23 | 21.28 | 21.23 | 21.26 | 1.57K |
| Aug 11, 2026 | 21.14 | 21.17 | 21.14 | 21.16 | 586 |
| Aug 10, 2026 | 21.09 | 21.17 | 21.06 | 21.13 | 1.9K |
| Aug 07, 2026 | 21.11 | 21.12 | 21.05 | 21.09 | 1.58K |
| Aug 06, 2026 | 21.33 | 21.34 | 21.29 | 21.31 | 2.34K |
| Aug 05, 2026 | 21.24 | 21.28 | 21.24 | 21.27 | 1.03K |
| Aug 04, 2026 | 21.11 | 21.22 | 21.10 | 21.22 | 3.75K |
| Aug 03, 2026 | 20.66 | 21.11 | 20.66 | 21.05 | 1.68K |
| Jul 31, 2026 | 20.99 | 21.05 | 20.87 | 20.96 | 6.29K |
| Jul 30, 2026 | 21.32 | 21.64 | 21.31 | 21.64 | 3.07K |
| Jul 29, 2026 | 21.41 | 21.49 | 21.27 | 21.27 | 1.47K |
| Jul 28, 2026 | 21.36 | 21.42 | 21.34 | 21.42 | 869 |
| Jul 27, 2026 | 21.48 | 21.48 | 21.47 | 21.48 | 1.96K |
The GraniteShares YieldBOOST Biotech ETF, an exchange-traded fund launched by GraniteShares Inc. under the umbrella of the GraniteShares ETF Trust, is managed by GraniteShares Advisors LLC. This U.S.-domiciled fund primarily allocates capital to the public stock markets within the United States. Its investment approach involves constructing its portfolio using derivative instruments, such as options, to gain exposure to companies operating across the healthcare, pharmaceutical, biotechnology, and life sciences industries. The ETF seeks a diverse selection of both growth and value stocks, encompassing businesses of varying market capitalizations.
| Employees | 0 |
| Beta | 0.56 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | N/A |
| Fiscal Year Ends | N/A |
| Sector | Financial Services |
| Industry | Asset Management - Leveraged |